MetLife (MET) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

05.02.26 01:00 Uhr

Werte in diesem Artikel
Aktien

66,37 EUR 1,17 EUR 1,79%

Indizes

PKT PKT

18.870,6 PKT 109,2 PKT 0,58%

3.404,3 PKT -17,6 PKT -0,51%

6.882,7 PKT -35,1 PKT -0,51%

MetLife (MET) reported $24.19 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 22.6%. EPS of $2.58 for the same period compares to $2.08 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $30.04 billion, representing a surprise of -19.47%. The company delivered an EPS surprise of +9.32%, with the consensus EPS estimate being $2.36.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Adjusted Revenue- Asia- Net investment income: $1.41 billion versus $1.38 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +12.3% change.Adjusted Revenue- Latin America- Premiums: $1.44 billion compared to the $1.24 billion average estimate based on three analysts. The reported number represents a change of +31.4% year over year.Adjusted Revenue- Asia- Premiums: $1.22 billion compared to the $1.23 billion average estimate based on three analysts. The reported number represents a change of +1.3% year over year.Adjusted Revenue- EMEA- Premiums: $679 million versus the three-analyst average estimate of $627.25 million. The reported number represents a year-over-year change of +19.5%.Revenue- Net investment income: $5.92 billion compared to the $5.5 billion average estimate based on four analysts. The reported number represents a change of +9.6% year over year.Revenue- Other Revenues: $737 million compared to the $661.92 million average estimate based on four analysts. The reported number represents a change of +15% year over year.Revenue- Universal life and investment-type product policy fees: $1.27 billion versus the four-analyst average estimate of $1.26 billion. The reported number represents a year-over-year change of +4.2%.Adjusted Revenue- Group Benefits- Other Revenues: $419 million versus $404.67 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +10.9% change.Total Adjusted Revenue- Group Benefits: $6.65 billion versus the three-analyst average estimate of $6.71 billion. The reported number represents a year-over-year change of +2.3%.Adjusted Revenue- Retirement & Income Solutions- Universal life and investment-type product policy fees: $104 million versus $98.69 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +5.1% change.Adjusted Revenue- Retirement & Income Solutions- Net investment income: $2.23 billion versus the three-analyst average estimate of $2.19 billion. The reported number represents a year-over-year change of +4%.Adjusted Revenue- Retirement & Income Solutions- Other Revenues: $75 million compared to the $62.52 million average estimate based on three analysts. The reported number represents a change of +23% year over year.View all Key Company Metrics for MetLife here>>>Shares of MetLife have returned -5.3% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Free Report: Profiting from the 2nd Wave of AI ExplosionThe next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.Investors who bought shares like Nvidia at the right time have had a shot at huge gains.But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen